Olympiad Research LP Buys New Position in Option Care Health, Inc. (NASDAQ:OPCH)

Olympiad Research LP bought a new stake in Option Care Health, Inc. (NASDAQ:OPCH) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 15,520 shares of the company’s stock, valued at approximately $360,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Westfield Capital Management Co. LP grew its position in Option Care Health by 10.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after buying an additional 599,589 shares in the last quarter. Global Alpha Capital Management Ltd. grew its position in Option Care Health by 108.3% in the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock valued at $1,559,000 after buying an additional 25,905 shares in the last quarter. Graypoint LLC bought a new position in Option Care Health in the 4th quarter valued at about $1,161,000. Victory Capital Management Inc. grew its position in Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after buying an additional 1,585,818 shares in the last quarter. Finally, Barclays PLC grew its position in Option Care Health by 180.1% in the 3rd quarter. Barclays PLC now owns 310,194 shares of the company’s stock valued at $9,708,000 after buying an additional 199,454 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Price Performance

OPCH stock opened at $32.00 on Friday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.63. The firm has a market capitalization of $5.45 billion, a PE ratio of 26.89, a P/E/G ratio of 2.30 and a beta of 1.35. The firm has a 50-day moving average of $27.71 and a two-hundred day moving average of $27.98.

Analyst Ratings Changes

A number of equities analysts recently issued reports on OPCH shares. UBS Group assumed coverage on shares of Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price for the company. Barrington Research raised their price objective on shares of Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a research report on Tuesday, January 14th. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Truist Financial reduced their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Finally, The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $32.25.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.